Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
During pregnancy, the non-classical major histocompatibility complex (MHC) class I HLA-G molecule is specifically expressed in trophoblast cells at the materno-fetal interface and may exert a local control of the immune response against viral infections. Human cytomegalovirus (HCMV) infection, which is the major cause of congenital defects, encodes multiple glycoproteins (US2, US3, US6, US10 and US11) that interrupt the MHC class I pathway of antigen presentation. The effect of some of these unique short (US) proteins on HLA-G expression has been previously studied, but little is known about the modulation of HLA-G cell surface expression during the course of HCMV infection which ensures expression of all of these US proteins. Using flow cytometry analysis, HLA-G cell surface expression was evaluated in HCMV-infected U373-HLA-G transfectant cells and compared with the modulation of the endogenous classical HLA-A2 molecules. The results indicated that HCMV infection down-modulated HLA-G cell surface expression, but later after infection and to a lesser extent than HLA-A2. Using various HLA-G/HLA-A2 chimeras, we showed that the unique structure of HLA-G cytoplasmic tail was partly involved in the resistance of HLA-G to viral down-modulation. Such limited down-modulation of HLA-G may have functional consequences in term of innate immunity against congenital HCMV infection.
Centre de Physiopathologie Toulouse-Purpan, INSERM U563, Hôpital Purpan, 31059 Toulouse Cedex 3, France.
Nathalie
N
Pizzato
Barbara
B
Garmy-Susini
Philippe
P
Le Bouteiller
Françoise
F
Lenfant
D000595:Amino Acid Sequence; D045744:Cell Line, Tumor; D003587:Cytomegalovirus / Q000235:genetics / Q000378:metabolism; D003586:Cytomegalovirus Infections / Q000378:metabolism*; D003593:Cytoplasm / Q000276:immunology / Q000378:metabolism / Q000821:virology; D004268:DNA-Binding Proteins / Q000032:analysis / Q000378:metabolism; D015536:Down-Regulation; D005260:Female; D006680:HLA Antigens / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D015789:HLA-A2 Antigen / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D015791:HLA-A3 Antigen / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008969:Molecular Sequence Data; D011247:Pregnancy; D017384:Sequence Deletion; D014764:Viral Proteins / Q000032:analysis / Q000235:genetics / Q000378:metabolism
D004268:DNA-Binding Proteins; D006680:HLA Antigens; D015789:HLA-A2 Antigen; D015791:HLA-A3 Antigen; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; C072217:ICP36 protein, Cytomegalovirus; D014764:Viral Proteins